The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

A total of 113 subjects were enrolled in the trial. Credit: SofikoS / Shutterstock. Palatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

RedHill Biopharma has begun a trial to assess the combination of opaganib and darolutamide for metastatic castrate-resistant ...